Previous 10 | Next 10 |
Antibiotics maker, Paratek Pharmaceuticals ( PRTK ), has struggled to hold onto gains in 2019. The has been a recent setback in the clinic but success on the funding front, both of which are worth discussing and the first focus of this article. Secondly, I look forward to a potential catalys...
Gainers: Iterum Therapeutics (NASDAQ: ITRM ) +121% . More news on: Iterum Therapeutics plc, Pintec Technology Holdings Limited, PDS Biotechnology Corporation, Stocks on the move, Read more ...
Melinta Therapeutics ( MLNT ) files for Chapter 11 as part as an agreement with its senior credit facility lenders — Deerfield Private Design Fund III and Deerfield Private Design Fund IV — that would sell the company to the lenders. More news on: Melinta Therapeutics...
MORRISTOWN, N.J., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT) (the “Company” or “Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, tod...
Gainers: Nortech Systems (NASDAQ: NSYS ) +98% . More news on: Nortech Systems Incorporated, FuelCell Energy, Inc., Cardlytics, Inc., Stocks on the move, Read more ...
Nano cap Melinta Therapeutics ( MLNT -44% ) slumps on more than double normal volume in reaction to its Q3 results . Highlights: More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Melinta Therapeutics ( MLNT ) Q3 results : Revenues: $15.9M (-53.4%). More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Melinta Therapeutics (NASDAQ: MLNT ): Q3 GAAP EPS of -$15.67 misses by $13.12 . Revenue of $15.87M (-53.4% Y/Y) misses by $0.43M . 10Q More news on: Melinta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,
MORRISTOWN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced that it has filed its quarterly report on Fo...
Vocera Communications (NYSE: VCRA ) -27% on Q3 earnings . More news on: Vocera Communications, Inc., Melinta Therapeutics, Inc., BeyondSpring Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Melinta Therapeutics Inc - Ordinary Shares Company Name:
MLNT Stock Symbol:
NASDAQ Market:
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotic...
Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company Continues Operations with No Anticipated Disruption to Product Supply or Support MO...